MAPK14 and breast carcinoma: Other groups reported p38-activation in highly proliferating and migrating MDA-MB-231 breast cancer cells [28], or p38-induced alterations in actin architecture and corresponding migration of human umbilical vein endothelial cells (HUVECs) [25].